By expenditures
| Name | Title | Type |
|---|---|---|
| Jacqueline Hassett | Executive Director | Auditee |
| Kaye Seible | FINANCE MANAGER | Auditee |
| Nicole Heldstab | Shareholder | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 352759 | 2024 | 2025-04-04 | Brady Martz & Associates PC | $3.10M |
| 296532 | 2023 | 2024-03-21 | Brady Martz & Associates PC | $2.90M |
| 53415 | 2022 | 2023-03-30 | Brady Martz & Associates PC | $2.90M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 352759 | 2024 | 2025-04-04 | 1130548 | 2024-004 | Material Weakness | - | L |
| 352759 | 2024 | 2025-04-04 | 1130547 | 2024-004 | Material Weakness | - | L |
| 352759 | 2024 | 2025-04-04 | 1130546 | 2024-004 | Material Weakness | - | L |
| 352759 | 2024 | 2025-04-04 | 1130545 | 2024-004 | Material Weakness | - | L |
| 352759 | 2024 | 2025-04-04 | 1130544 | 2024-004 | Material Weakness | - | L |
| 352759 | 2024 | 2025-04-04 | 1130543 | 2024-004 | Material Weakness | - | L |
| 352759 | 2024 | 2025-04-04 | 1130542 | 2024-004 | Material Weakness | - | L |
| 352759 | 2024 | 2025-04-04 | 1130541 | 2024-004 | Material Weakness | - | L |
| 352759 | 2024 | 2025-04-04 | 1130540 | 2024-004 | Material Weakness | - | L |
| 352759 | 2024 | 2025-04-04 | 1130539 | 2024-004 | Material Weakness | - | L |
| 352759 | 2024 | 2025-04-04 | 1130538 | 2024-004 | Material Weakness | - | L |
| 352759 | 2024 | 2025-04-04 | 1130537 | 2024-004 | Material Weakness | - | L |
| 352759 | 2024 | 2025-04-04 | 1130536 | 2024-004 | Material Weakness | - | L |
| 352759 | 2024 | 2025-04-04 | 1130535 | 2024-003 | - | Yes | N |
| 352759 | 2024 | 2025-04-04 | 554106 | 2024-004 | Material Weakness | - | L |
| 352759 | 2024 | 2025-04-04 | 554105 | 2024-004 | Material Weakness | - | L |
| 352759 | 2024 | 2025-04-04 | 554104 | 2024-004 | Material Weakness | - | L |
| 352759 | 2024 | 2025-04-04 | 554103 | 2024-004 | Material Weakness | - | L |
| 352759 | 2024 | 2025-04-04 | 554102 | 2024-004 | Material Weakness | - | L |
| 352759 | 2024 | 2025-04-04 | 554101 | 2024-004 | Material Weakness | - | L |
| 352759 | 2024 | 2025-04-04 | 554100 | 2024-004 | Material Weakness | - | L |
| 352759 | 2024 | 2025-04-04 | 554099 | 2024-004 | Material Weakness | - | L |
| 352759 | 2024 | 2025-04-04 | 554098 | 2024-004 | Material Weakness | - | L |
| 352759 | 2024 | 2025-04-04 | 554097 | 2024-004 | Material Weakness | - | L |
| 352759 | 2024 | 2025-04-04 | 554096 | 2024-004 | Material Weakness | - | L |
| 352759 | 2024 | 2025-04-04 | 554095 | 2024-004 | Material Weakness | - | L |
| 352759 | 2024 | 2025-04-04 | 554094 | 2024-004 | Material Weakness | - | L |
| 352759 | 2024 | 2025-04-04 | 554093 | 2024-003 | - | Yes | N |
| 296532 | 2023 | 2024-03-21 | 959781 | 2023-004 | - | Yes | N |
| 296532 | 2023 | 2024-03-21 | 959780 | 2023-004 | - | Yes | N |
| 296532 | 2023 | 2024-03-21 | 959779 | 2023-003 | Significant Deficiency | - | AB |
| 296532 | 2023 | 2024-03-21 | 959778 | 2023-003 | Significant Deficiency | - | AB |
| 296532 | 2023 | 2024-03-21 | 383339 | 2023-004 | - | Yes | N |
| 296532 | 2023 | 2024-03-21 | 383338 | 2023-004 | - | Yes | N |
| 296532 | 2023 | 2024-03-21 | 383337 | 2023-003 | Significant Deficiency | - | AB |
| 296532 | 2023 | 2024-03-21 | 383336 | 2023-003 | Significant Deficiency | - | AB |
| 53415 | 2022 | 2023-03-30 | 623636 | 2022-004 | - | - | N |
| 53415 | 2022 | 2023-03-30 | 623635 | 2022-003 | Significant Deficiency | - | ABH |
| 53415 | 2022 | 2023-03-30 | 623634 | 2022-004 | - | - | N |
| 53415 | 2022 | 2023-03-30 | 623633 | 2022-003 | Significant Deficiency | - | ABH |
| 53415 | 2022 | 2023-03-30 | 47194 | 2022-004 | - | - | N |
| 53415 | 2022 | 2023-03-30 | 47193 | 2022-003 | Significant Deficiency | - | ABH |
| 53415 | 2022 | 2023-03-30 | 47192 | 2022-004 | - | - | N |
| 53415 | 2022 | 2023-03-30 | 47191 | 2022-003 | Significant Deficiency | - | ABH |